President Trump should take real steps to actually lower drug prices, including enforcing a strong crackdown on drug middlemen...
Enforce a strong crackdown on drug middlemen to help lower prescription drug prices.
Occurrences
Reducing out-of-pocket drug costs by continuing to crack down on middlemen;
Welch, Cornyn, Rosen, Tillis Introduce Bipartisan Bill to Lower Prescription Drug Costs for Seniors ... The Senators’ bill creates greater patient savings at the pharmacy counter by requiring full rebate pass-through for chronic condition medicines in the deductible or when patients owe coinsurance. ... 'I’m proud to join this bipartisan bill to ensure that seniors with chronic medical conditions get the savings negotiated by pharma, PBMs, and insurers.'
Evidence
U.S. Senators Roger Marshall and Peter Welch introduced the Drug Price Transparency in Medicaid Act of 2023, aiming to limit abusive pricing practices by pharmacy benefit managers (PBMs), including 'spread pricing,' where PBMs charge Medicaid more than they pay pharmacies for a drug. The bill is projected to save Medicaid an estimated $1 billion over 10 years.
Senators Peter Welch, John Cornyn, Jacky Rosen, and Thom Tillis introduced the Share the Savings with Seniors Act of 2025, which aims to lower out-of-pocket prescription drug costs for seniors by ensuring that patients directly benefit from savings negotiated by PBMs and insurers. The bill requires full rebate pass-through for chronic condition medicines in the deductible or when patients owe coinsurance.
Senators Peter Welch and Amy Klobuchar reintroduced the Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act, aiming to expand Medicare's ability to negotiate drug prices, thereby lowering costs for consumers and reducing federal spending. The legislation seeks to increase the number of prescription drugs subject to negotiation and accelerate the negotiation timeline.
Senators Mark Warner, Peter Welch, Roger Marshall, and Bill Cassidy introduced the Protecting Pharmacies in Medicaid Act, targeting PBMs' use of 'spread pricing,' where PBMs charge Medicaid more than they pay pharmacies for a drug. The bill is projected to save Medicaid an estimated $2 billion over 10 years.
Key provisions from Senator Peter Welch’s bipartisan Drug Price Transparency in Medicaid Act were included in The Modernizing and Ensuring PBM Accountability Act, a bipartisan package aimed at holding PBMs accountable for rising prescription drug prices.
Senator Maria Cantwell called on colleagues to pass the Pharmacy Benefit Manager Transparency Act, which aims to hold PBMs accountable for deceptive and unfair practices that drive up drug costs. The bill has bipartisan support and is cosponsored by Senator Peter Welch.
Senators Peter Welch and Josh Hawley introduced a bill seeking to lower drug prices by cracking down on 'patent thickets,' a practice used by pharmaceutical companies to extend monopolies on drugs and delay generic competition.
Senators Peter Welch and Jeff Merkley introduced the 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support (PATIENTS) Act, aiming to protect the 340B drug pricing program and ensure patients, especially those in lower-income and rural communities, have access to affordable medications.
Assessments
Senator Peter Welch has repeatedly cosponsored, introduced, or led bipartisan legislation targeting pharmacy benefit managers (PBMs) and other drug middlemen, specifically aiming to increase transparency, enforce regulations against abusive pricing practices, and ensure cost savings reach patients. These efforts directly address the promise to crack down on drug middlemen. However, available evidence shows the activity is primarily legislative proposals, bills, and inclusion of provisions in legislative packages rather than the passage and enforcement of comprehensive reforms into law that would constitute a full, strong crackdown. Thus, while consistent and meaningful effort is evident, the ultimate policy delivery is ongoing and incomplete.